TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

QUESTCOR PHARMA

OncologyInfectious DiseaseImmunology
Pharma

QUESTCOR PHARMA is a pharmaceutical company focused on Oncology, Infectious Disease, Immunology.

2010
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 36%
0 drugs Phase 3: 3 Phase 1: 2
Infectious Disease 21%
0 drugs Phase 3: 1 Phase 2: 2
Immunology 15%
1 drugs
Neurology 15%
1 drugs
Dermatology 13%
0 drugs Phase 3: 1 Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Immunology
AbbVie big-pharma
Immunology, Oncology, Neurology, Infectious Disease
GSK big-pharma
Infectious Disease, Oncology, Immunology, Neurology
Eli Lilly big-pharma
Oncology, Immunology, Neurology, Dermatology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Infectious Disease, Neurology